Nations Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Sell |
555
-36
| -6% | -$14.6K | 0.02% | 620 |
|
|
2025
Q1 | $294K | Sell |
591
-112
| -16% | -$55.8K | 0.02% | 536 |
|
|
2024
Q4 | $366K | Sell |
703
-10
| -1% | -$5.21K | 0.03% | 513 |
|
|
2024
Q3 | $441K | Sell |
713
-1
| -0.1% | -$619 | 0.03% | 476 |
|
|
2024
Q2 | $395K | Sell |
714
-15
| -2% | -$8.3K | 0.03% | 473 |
|
|
2024
Q1 | $424K | Buy |
729
+71
| +11% | +$41.3K | 0.04% | 455 |
|
|
2023
Q4 | $349K | Sell |
658
-51
| -7% | -$27.1K | 0.03% | 482 |
|
|
2023
Q3 | $359K | Sell |
709
-96
| -12% | -$48.6K | 0.04% | 456 |
|
|
2023
Q2 | $420K | Buy |
805
+80
| +11% | +$41.7K | 0.04% | 418 |
|
|
2023
Q1 | $418K | Sell |
725
-25
| -3% | -$14.4K | 0.04% | 403 |
|
|
2022
Q4 | $413K | Sell |
750
-687
| -48% | -$378K | 0.05% | 397 |
|
|
2022
Q3 | $729K | Sell |
1,437
-338
| -19% | -$171K | 0.11% | 214 |
|
|
2022
Q2 | $964K | Sell |
1,775
-4
| -0.2% | -$2.17K | 0.13% | 198 |
|
|
2022
Q1 | $1.05M | Sell |
1,779
-2,784
| -61% | -$1.64M | 0.13% | 188 |
|
|
2021
Q4 | $3.05M | Buy |
4,563
+2,883
| +172% | +$1.92M | 0.4% | 55 |
|
|
2021
Q3 | $960K | Sell |
1,680
-568
| -25% | -$325K | 0.15% | 170 |
|
|
2021
Q2 | $1.13M | Buy |
2,248
+74
| +3% | +$37.3K | 0.19% | 144 |
|
|
2021
Q1 | $992K | Buy |
2,174
+158
| +8% | +$72.1K | 0.23% | 126 |
|
|
2020
Q4 | $939K | Buy |
2,016
+97
| +5% | +$45.2K | 0.25% | 116 |
|
|
2020
Q3 | $847K | Buy |
1,919
+7
| +0.4% | +$3.09K | 0.26% | 109 |
|
|
2020
Q2 | $693K | Buy |
1,912
+107
| +6% | +$38.8K | 0.25% | 124 |
|
|
2020
Q1 | $512K | Buy |
1,805
+426
| +31% | +$121K | 0.22% | 139 |
|
|
2019
Q4 | $448K | Sell |
1,379
-44
| -3% | -$14.3K | 0.15% | 177 |
|
|
2019
Q3 | $430K | Buy |
+1,423
| New | +$430K | 0.15% | 182 |
|